Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Overview of attention for article published in JACC, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 4 public wall posts from 2 users.

CHAMPION results evaluating efficacy/safety of cangrelor compared w/ clopidogrel, +/- GPI #JACC http://ow.ly/7FrI307YlA2 pic.twi…

Cangrelor reduces periprocedural ischemic complications irrespective of GPI use. #JACC http://ow.ly/UTB1307YliS pic.twitter.com…

Cangrelor is a promising alternative to glycoprotein IIb/IIIa inhibitors during PCI. Read more in #JACC http://ow.ly/mFik307Yl7r…

Editors' Insights: What is the role of cangrelor during percutaneous coronary intervention? New analysis from CHAMPION shows…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.